Source of the article:SiYu MedTech
Reprint requirements: Can be reprinted 24 hours after the first publication, source must be cited.
On June 20, 2024, Johnson & Johnson Medical Technologies (NYSE:JNJ) released itsAn Open and Secure Digital Ecosystem——Polyphonic, which can provide a more connected surgical experience.
The characteristics of the ecosystem areSoftware applications are independent of data sources., and focus on providing insights at the most critical times and places. Future versions will offer an open and secure development platform and marketplace for curated digital solutions.# Polyphonic Digital EcosystemPolyphonic Digital EcosystemThe first version is now available to some hospitals., which containsFor surgical video, telepresence, and planningPolyphonic SolutionsApplication, which can help surgeons and surgical teams enhance collaboration in an integrated, user-centered solution built specifically for healthcare institutions.PolyphonicEcosystem'sThe first version focuses on video., videos are an important data source in today's surgical procedures.A one-minute surgical video is equivalent to a high-resolution image.CTAmount of Image Data25Times more, its potential lies in helping surgeons better manage, tag, edit, and safely share de-identified videos to improve pre-operative, intra-operative, and post-operative workflows and collaboration.Other features released for the first time includeRemote Presence and Case Planning Features, to help address collaboration, peer training, andOREfficiency issues in workflow.
Future versions will target a broader digital surgery ecosystem, providing creators and developers withPolyphonic StudioAndPolyphonic Store, to provide secure access to well-planned digital solutions.
Polyphonic StudioWill be built on a secure operating environment, providing data management, advanced analytics, edge computing and connectivity, as well as design and development toolkits to make it easier for creators and developers to build and scale surgical software solutions.
The studio will provide artificial intelligence(AI)Function, leveraging the collaboration between Johnson & Johnson Medical Technologies and NVIDIA to expand artificial intelligence in the surgical field.Hani Abouhalka, Chairman of Johnson & Johnson MedTech Surgical Group, said: "As the value of surgical data continues to growPromotion, The development trend in the field of surgical operations is to provide a more interconnected experience for patients, medical teams, and hospitals. OurSurgical Techniques and Surgical SoftwareSolution"Widely used around the world, so we prioritize openness and innovation to provide doctors and patients with a more user-friendly, adaptable, and interconnected surgical experience."As part of a targeted testing program for specific hospitals, Johnson & Johnson has provided the Polyphonic Digital Ecosystem to the Meander Medical Center in Amersfoort, Netherlands.Ivo Broeders, MD, surgeon at Meander Medical Center and head of the Artificial Intelligence Lab, stated:"Digitization will completely transform the future of surgery, and we are proud to be a pioneer in the digital field. We are delighted to test Johnson & Johnson's new digital ecosystem, which also contributes to the advancement of the healthcare sector."# In Collaboration with NVIDIA2024March,Johnson & Johnson announcedLeader in the Field of Artificial Intelligence ComputingNvidia's collaboration has prepared the Studio features.The two companies collaborated to support increased access to real-time analytics and the availability of global AI algorithms. Johnson & Johnson stated that it developed Studio to provide these AI capabilities.Shan Jegatheeswaran, Global Vice President of Digital at Johnson & Johnson Medical Technologies, stated:"Medical experts and technicians see the opportunity to improve treatment outcomes by providing insights on a large scale, so innovation in the surgical field is accelerating. The Polyphonic digital ecosystem provides surgeons with the technology they need today to support critical use cases while building a more open and interconnected digital surgery future."# About Johnson & Johnson
Johnson & Johnson (NYSE: JNJ) was founded in 1886 and is the world's most comprehensive healthcare enterprise with a wide range of business operations, coveringConsumer Goods, Pharmaceuticals, Medical DevicesThree major fields.Headquartered in New Brunswick, New Jersey, USA, with more than 260 operating companies in over 60 countries and regions worldwide, and a global workforce exceeding 140,000 employees.April 17, 2024, Johnson & JohnsonAnnounce Q1 Earnings Report for Fiscal Year 2024, Total Revenue$213.83 billion (approximately RMB 1,547.89 billion)`, year-on-year`Growth of 2.3%.On May 31, 2024, Johnson & Johnson announced the completion of its acquisition for $13.1 billion (approximately 94.864 billion RMB).Shockwave MedicalThe acquisition.It is reported that Johnson & Johnson intends to appoint Michael Bodner, currently serving as the Global Head of Cardiac Recovery at Abiomed, to oversee this business.
Editor-in-Chief | Zhao Qing Reviewed by | Yi He
